resulting from allegations that Curaleaf may have issued materially misleading business information to the investing public. On July 22, 2019, the FDA sent a warning letter to Curaleaf stating that …
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Curaleaf Holdings, Inc. – CURLF
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Curaleaf Holdings, Inc. – CURLF
Leave a reply